(Q34040005)

English

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

anti-retroviral agent

0 references

0 references

Charles van der Horst

9

object named as

Charles van der Horst

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Catherine Orrell

object named as

Catherine Orrell

5

0 references

Matthew Patrick Fox

object named as

Matthew P Fox

1

0 references

11

object named as

Robin Wood

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

object named as

Prudence Ive

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Ian M Sanne

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Francesca Conradie

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jennifer Zeinecker

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Mohammed Rassool

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Marjorie Dehlinger

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

James McIntyre

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2041-2050

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

When to start antiretroviral therapy in resource-limited settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Effect of early versus deferred antiretroviral therapy for HIV on survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Should HIV therapy be started at a CD4 cell count above 350 cells/microl in asymptomatic HIV-1-infected patients?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

When should antiretroviral therapy for HIV be started?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

Sexual transmission of HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

5 July 2018

The search for data on when to start treatment for HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

28 October 2018

Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

28 October 2018

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

28 October 2018

When To Start Therapy for HIV Infection: A Swinging Pendulum in Search of Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2914833

28 October 2018

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20613459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microL

1 reference

https://pubmed.ncbi.nlm.nih.gov/20613459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort

1 reference

https://pubmed.ncbi.nlm.nih.gov/20613459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa

1 reference

https://pubmed.ncbi.nlm.nih.gov/20613459

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAD.0B013E32833C703E

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34040005&oldid=1739634191"